Live from the NIH registry
Studies recruiting near Enterprise right now
Top 25 of 455 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (12.5 mi)
· Sponsor: SWOG Cancer Research Network
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (12.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada (12.5 mi)
· Sponsor: National Cancer Institute (NCI)
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Relapsing Multiple Sclerosis
Phase 4
Interventional 100 participants sought
Cleveland Clinic — Las Vegas, Nevada (12.5 mi)
· Sponsor: University of Colorado, Denver
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Las Vegas, Nevada (12.5 mi)
· Sponsor: Sameek Roychowdhury
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Chronic Low Back Pain
N/A
Interventional 2,529 participants sought
VA Southern Nevada Healthcare System, North Las Vegas, NV — North Las Vegas, Nevada (14.5 mi)
· Sponsor: VA Office of Research and Development
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (12.5 mi)
· Sponsor: NRG Oncology
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Las Vegas, Nevada (12.5 mi)
· Sponsor: AstraZeneca
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Las Vegas Clinical Trials — North Las Vegas, Nevada (14.5 mi)
· Sponsor: Crystalys Therapeutics
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (12.5 mi)
· Sponsor: Eli Lilly and Company
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Major Depressive Disorder (MDD)
Phase 2
Interventional 300 participants sought
Draig Clinical Site — Las Vegas, Nevada (12.5 mi)
· Sponsor: Draig Therapeutics Ltd
Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults
Antiviral Drug
Phase 1
Interventional 48 participants sought
PPD Las Vegas Clinical Research Unit — Las Vegas, Nevada (12.5 mi)
· Sponsor: Just-Evotec Biologics
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
Liver Fibrosis, Hepatic Cirrhosis
Phase 2
Interventional 104 participants sought
Research Site — Las Vegas, Nevada (12.5 mi)
· Sponsor: AstraZeneca
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-072 — Las Vegas, Nevada (12.5 mi)
· Sponsor: Biohaven Therapeutics Ltd.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (12.5 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (12.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1144 — Las Vegas, Nevada (12.5 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Excel Clinical Research, LLC — Las Vegas, Nevada (12.5 mi)
· Sponsor: Pfizer
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients
Irritability Associated With Autism Spectrum Disorder
Phase 3
Interventional 160 participants sought
Vector Clinical Trials — Las Vegas, Nevada (12.5 mi)
· Sponsor: Intra-Cellular Therapies, Inc.
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Las Vegas, Nevada (12.5 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
A Study of VV-14305 for the Treatment of Thyroid Eye Disease
Thyroid Eye Disease (TED)
Phase 1, Phase 2
Interventional 135 participants sought
Kriya Clinical Trial Site — Las Vegas, Nevada (12.5 mi)
· Sponsor: Kriya Therapeutics, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Digestive Disease Specialists - Las Vegas - Crimson Canyon Drive — Las Vegas, Nevada (12.5 mi)
· Sponsor: Eli Lilly and Company
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
Acute Stroke, Ischemic Stroke
Phase 2, Phase 3
Interventional 728 participants sought
University Medical Center of Southern Nevada — Las Vegas, Nevada (12.5 mi)
· Sponsor: DiaMedica Therapeutics Inc
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
AB Clinical Trials — Las Vegas, Nevada (12.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Jubilee Clinical Research NV. LLC — Las Vegas, Nevada (12.5 mi)
· Sponsor: Eli Lilly and Company